Pharmacist-Intensivist Collaborative Telehealth for Post-Intensive Care Syndrome
NCT ID: NCT06983496
Last Updated: 2025-09-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
24 participants
INTERVENTIONAL
2025-06-01
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study intervention will be telehealth follow-up appointments provided by clinical pharmacists at approximately one and three months post-hospital discharge. The purpose of the follow-up appointments will be to assess for post-intensive care syndrome and provide recommend interventions aimed at improving recovery
Participants will randomized to receive the study intervention or standard of care.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Daily Sedative Interruption in Critically Ill Patients Being Managed With a Sedation Protocol
NCT00298493
Improving Psychological Outcomes for Acute Respiratory Failure Survivors Using a Self-Management Intervention
NCT06341972
Neuromodulation for Prevention of Intensive Care Unit Acquired Weakness and Post Intensive Care Syndrome
NCT06238609
Pilot Physiological Evaluation of an Investigational Mask with Expiratory Washout.
NCT06007495
The Efficacy of P0.1-guided Sedation Protocol in Critically Ill Patients Receiving Invasive Mechanical Ventilation: A Randomized Controlled Trial
NCT06203405
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Telehealth Intervention Group
This group will receive the study intervention (i.e. telehealth follow-up appointments at approximately one and three months post-hospital discharge).
Post-ICU Telehealth Follow-up
The post-ICU clinic follow-up will be conducted by a pharmacist via a telehealth visit. A collaborating physician (i.e. intensivist) will provide clinical support and oversight as needed. The appointments will be 30-60 minute telephone/video calls. Participants be assessed for PICS and recommended interventions to improve their care.
Standard of Care Group
This group will receive standard post-ICU care following hospital discharge.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Post-ICU Telehealth Follow-up
The post-ICU clinic follow-up will be conducted by a pharmacist via a telehealth visit. A collaborating physician (i.e. intensivist) will provide clinical support and oversight as needed. The appointments will be 30-60 minute telephone/video calls. Participants be assessed for PICS and recommended interventions to improve their care.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Required admission to either medical or surgical ICU
* Respiratory failure requiring invasive mechanical ventilation of at least 24 hours during ICU stay; or ICU stay of at least 7 days
* Anticipated discharge to home after hospitalization
* Consent from patients themselves or a legally authorized representative if necessary
Exclusion Criteria
* Incarceration/Imprisonment
* Life expectancy less than 6 months or enrolled in hospice/palliative care
* Anticipated discharge to skilled nursing facility, medical rehabilitation facility, or other long terms care facility
* Unable to participate in telehealth
18 Years
89 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Malcom Randall VA Medical Center
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Andrew Franck
Clinical Pharmacy Specialist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Malcom Randall Veterans Affairs Medical Center
Gainesville, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB202401793
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.